Literature DB >> 17490436

Infection with Salmonella typhimurium has no effect on the composition and cleavage specificity of the 20S proteasome in human lymphoid cells.

Miguel Marcilla1, José Antonio López de Castro, José G Castaño, Iñaki Alvarez.   

Abstract

Human leucocyte antigen (HLA)-B27 is strongly associated with spondyloarthropathies, including reactive arthritis. Several Gram-negative bacteria, such as Salmonella typhimurium, can trigger this disease. It has been suggested that peptides derived from bacterial proteins and presented by HLA-B27 to cytotoxic T lymphocytes might show molecular mimicry with autologous peptides, leading to T-cell cross-reaction and autoimmunity. Antigen presentation in Salmonella-infected cells could be modulated by changes in the composition of the proteasome, which is the major proteolytic system that generates major histocompatibility complex class I ligands. In this study we analysed whether the composition or activity of the 20S proteasome was altered upon infection of lymphoid cells by S. typhimurium. Two-dimensional gel electrophoresis failed to show any differences between the composition of 20S proteasomes from cells infected with S. typhimurium for 24 hr, relative to non-infected cells. In addition, digestions of oxidized insulin B-chain with purified 20S proteasomes from non-infected and infected cells generated the same products, indicating that the proteasomal cleavage specificity was not altered upon infection. These data indicate that infection of lymphoid cells by S. typhimurium fails to induce formation of immunoproteasomes or otherwise alter the proteolytic specificity of the 20S proteasome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490436      PMCID: PMC2265988          DOI: 10.1111/j.1365-2567.2007.02624.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

Review 1.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

2.  Antibodies against the C2 COOH-terminal region discriminate the active and latent forms of the multicatalytic proteinase complex.

Authors:  J Arribas; P Arizti; J G Castaño
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

Review 3.  Current perspectives in reactive arthritis.

Authors:  G Kingsley; J Sieper
Journal:  Immunol Today       Date:  1993-08

4.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

5.  Existence of a molecular ruler in proteasomes suggested by analysis of degradation products.

Authors:  T Wenzel; C Eckerskorn; F Lottspeich; W Baumeister
Journal:  FEBS Lett       Date:  1994-08-01       Impact factor: 4.124

6.  Kinetic studies of the differential effect of detergents on the peptidase activities of the multicatalytic proteinase from rat liver.

Authors:  J Arribas; J G Castaño
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

7.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.

Authors:  J Zemmour; A M Little; D J Schendel; P Parham
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

8.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

9.  Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase.

Authors:  I Ruiz de Mena; E Mahillo; J Arribas; J G Castaño
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

10.  Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines.

Authors:  G M Verjans; J H Ringrose; L van Alphen; T E Feltkamp; J G Kusters
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.